期刊文献+

肺癌致上腔静脉综合征综合治疗分析 被引量:7

Combined treatment of superior vena cava syndrome from lung cancer
暂未订购
导出
摘要 [目的]探讨以冲击化疗为主后行放射治疗肺癌所致上腔静脉综合征的综合治疗临床效果。[方法]回顾分析31例肺癌致上腔静脉压迫综合征患者,先联合化疗;小细胞肺癌用CE(CBP;VP-16)或COME(CTX;VCR;MTX;VP-16)方案、非小细胞肺癌用CAP(CTX;ADM;PDD)或MVP(MMC;VDS;PDD)方案,配合消炎、利水、抗凝等综合治疗,症状体征缓解后开始放射治疗,总剂量DT4000~6000CGY,放疗结束3~4周再加强1个周期化疗。[结果]31例肺癌所致上腔静脉压迫综合征患者经上述治疗后完全缓解(CR)15/31(48.3%),部分缓解(PR)10/31(32.2%),无变化(NC)4/31(12.9%),进展(PD)2/31(6.4%),总有效率(CR+PR)25/31(80.6%)。[结论]肺癌所致上腔静脉压迫综合征患者首先以冲击化疗为主的综合治疗措施,后行放疗对病情缓解,改善生活质量有利。 [ Objective] This study is an investigation of the combined treatment of superior vena cava syndrome (SVCS) from lung cancer patients. [ Methods ] Clinical data of 31 patients with SVCS from lung cancer admitted to the hospital were retrospectively analyzed. The patients had been undergone chemotherapy as follows: Patients with small cell lung cancer were treated with CE ( CBP ; VP - 16) or COME ( CTX ; VCR ; MTX ; VP - 16), while those with Non - small cell lung cancer were treated with CAP( CTX ; ADM ; PDD) or MVP( MMC ; VDS ; PDD), companied by anti - infection, anticoagulation and so on. When symptom had been relieved, radiotherapy was applied with dose arrange from 4000 to 6000 CGY. After the 3 to 4 week rest, one period of chemotherapy was used. [ Results] In whole group , complete response (CR) was achieved in 15 patients (48.3%), partial response (PR) was found in 10 patients (32.2%), no change (NC) was seen in 4 patients ( 12.9% ), progressive disease (PD) was observed in 2 patients (6.4%) and the overall response rate ( CR + PR) reached 80.6 %. [ Conclusion] The combined treatment with chemotherapy followed by radiotherapy is good for patients with SVCS from lung cancer.
作者 李革 卜敏锐
出处 《大连医科大学学报》 CAS 2009年第2期198-199,203,共3页 Journal of Dalian Medical University
关键词 上腔静脉综合征 肺肿瘤 化疗 放疗 superior vena cana syndrome lung carcinoma radiotherapy chemotherapy
  • 相关文献

参考文献5

二级参考文献8

  • 1Dosoretz DE, Galmarini D, Rubenstein JH, et al . Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication[J]. Int J Radiat Oncol Biol Phys, 1993,27(3):507 - 516.
  • 2Bradley JD, Ieumwananonthachai N, Purdy JA, et al.Critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non - small-cell lung carcinoma[J]. Int J Radiat Oncol Biol Phys,2002,52(1):49 - 57.
  • 3Grills IS, Yan D, Martinez AA, Vicini FA, et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non - small - cell lung cancer: a comparison of intensity- modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation[J]. Int J Radiat Oncol Biol Phys, 2003, 57(3):875- 890.
  • 4Walport MJ. Complement Second of two parts[J]. N Engl J Med, 2001,344(15):1140- 1144.
  • 5Jurianz K, Ziegler S, Garcia- Schuler H, et al. Complement resistance of tumor cells: basal and induced mechanisms[J]. Mol Immunol, 1999,36(13-14): 929-939.
  • 6Jeanfaive T, Pegis JD, Encm B, et al. Sugical vein reconstruction in Patients with tumor invasiveness of the superior vena caval syndrome[J]. Retrospective study of 7 cases. J Chir Paris. 1996,33(2):6.
  • 7汪忠镐,谷涌泉,汪秀杰,王仕华.上腔静脉综合征的外科治疗(附47例分析)[J].中华胸心血管外科杂志,1998,14(2):81-83. 被引量:17
  • 8江素华,曾波航,李宇清,关广雄,黄慧.80例肺癌患者免疫球蛋白、补体及CEA分析[J].肿瘤防治杂志,2000,7(4):367-369. 被引量:2

共引文献8

同被引文献55

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部